How is Incyte (INCY) doing?
Incyte is a company in the biotechnology industry, based in Wilmington, DE, worth $22.9B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.
Updated Oct 9, 2026
Middling
Incyte shares are up 32% over the past year, 14 points ahead of the S&P 500. Its type is Churning Winner. Among large US stocks and funds it ranks in the 80th percentile on market beat, the 36th on staying power and the 99th on business growth. It appears on 12 of our dashboards, including 2nd on “Which companies have more cash than debt?” and 3rd on “Which companies do analysts expect to grow fastest?”.
Compare with VRTX · ALNY · BMRN · EXEL · INSP · NBIX
Financials, earnings and news on Stox ›The past year
Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.
What kind of stock is it?
Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.
Churning Winner
Beating the market on a growing business, but erratically, and with sellers in charge lately.
Churning Winner since Sep; Hot Hand before that.
Also Churning Winner (52 in all): MEDP · DGX · SHC · HLT · CRS · BWA
How is it doing against its group?
Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.
Incyte is +32% over the past year, against +20% for the rest of the group and +16% for the S&P 500. It ranks 25th of 86 in Health care.
How much does it move?
Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.
About usual Incyte typically moves 2.9% in a day, about usual for it, and it swings more than 50% of large US stocks.
INCY on our dashboards
Every question where Incyte appears, in the order of the home page, with its reading and place in that table. Select a question to open it with INCY highlighted. Select a column to sort.
| Question | Reading | Place | Details |
|---|---|---|---|
| Which companies do analysts expect to grow fastest? Earnings | 100Fast | 3 of 60 | EPS growth +127% · This year 3.76 · Next year 8.54 |
| Which stocks show persistent price growth and business growth? Leading stocks | 66Strong | 56 of 60 | Pressure 21 · 1Y +32% |
| Which companies are growing fastest? Business quality | 91Fast | 47 of 60 | Revenue, 1Y +27% · Change +8 pts · Earnings, 1Y +85% |
| Who is outgrowing its rivals? Business quality | 92Outgrowing | 41 of 60 | Revenue, 1Y +27% · Rivals +11% · Lead +16 pts |
| Whose profit margins are widening? Business quality | 93Widening | 28 of 60 | Change, 1Y +10.4 pts · Operating margin 32% · Gross margin 93% |
| Which businesses are getting better? Business quality | 99Improving | 5 of 60 | Revenue growth +21% · Cash-flow growth +402% · Operating margin 27% |
| Which companies earn the most on their capital? Business quality | 97Excellent | 13 of 60 | Return on capital 24% · Gross margin 93% · Cash margin 33% |
| Which companies get the most from each employee? Business quality | 93Lean | 34 of 60 | Revenue / employee $2.2M · Profit / employee $625K · Value / employee $8.1M |
| Which companies invest the most in research? Business quality | 97Heavy | 7 of 60 | R&D / revenue 37.0% · R&D a year $2.2B · R&D, 1Y +9% |
| Which stocks are cheap against their own history? Value | 99Cheap | 28 of 60 | P/E now 14.4x · 10-yr median 70.9x · Earnings, 1Y +78% |
| Which stocks are cheaper than their rivals? Value | 88Cheaper | 54 of 60 | P/E 14.4x · Rivals’ P/E 25.3x · Growth gap +16 pts |
| Which companies have more cash than debt? Value | 100Net cash | 2 of 60 | Net cash $4.5B · % of value +18% · Debt payback 0.0 yrs |
Go deeper on Stox
INCY’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.
How to read this page
How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.
Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.
Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.
Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.
Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.
For financial statements, earnings and news, see INCY’s full profile on Stox.
This page is information, not investment advice. About our data and methods ›